TMCC3

TMCC3 is an endoplasmic reticulum transmembrane protein that shapes the tubular ER network by localizing specifically to ER tubule three-way junctions (PMID:31696206). It self-assembles into oligomers and is anchored in the ER through its transmembrane domains, while its N-terminal coiled-coil domain directs the protein to three-way junctions (PMID:27697108, PMID:31696206). TMCC3 binds atlastin GTPases through its C-terminal transmembrane segments, and TMCC3 loss reduces three-way junctions and expands ER sheets—a phenotype partially rescued by atlastin-2 overexpression, establishing that TMCC3 supports atlastin activity in promoting the reticular ER (PMID:31696206). Junction localization is negatively regulated by phosphorylation-dependent binding of 14-3-3γ to the TMCC3 N-terminus, which displaces TMCC3 from three-way junctions and remodels the ER network (PMID:36549645). Beyond ER morphogenesis, TMCC3 directly binds AKT via its N-terminal 1–153 residue domain and positively regulates AKT activation, and this interaction drives breast cancer stem cell self-renewal and metastasis (PMID:33742122). TMCC3 transcription is directly activated by PPARγ through a responsive element in its 5' region, accounting for elevated expression in fatty liver (PMID:39326649).

1. 2016 Medium

   Establishing where TMCC3 resides and how it is organized was the first step in defining its cellular role, showing it is an ER-anchored protein that oligomerizes and engages 14-3-3 proteins.

   Evidence Deletion-mutant expression, confocal immunostaining, and immunoprecipitation/mass spectrometry of recombinant TMCC3

   PMID:27697108

   Open questions at the time

   • The functional consequence of oligomerization was not defined
   • The specific 14-3-3 isoform and the regulatory role of the interaction were not resolved
2. 2019 High

   This work resolved the molecular function of TMCC3 in ER architecture, demonstrating that it concentrates at three-way junctions via its coiled-coil domain and supports atlastin-driven formation of the tubular ER network.

   Evidence Domain-truncation mapping, fluorescence microscopy, RNAi knockdown with defined ER-morphology phenotype, and atlastin-2 overexpression rescue in U2OS cells

   PMID:31696206

   Open questions at the time

   • The biochemical mechanism by which TMCC3 enhances atlastin GTPase activity was not determined
   • Whether junction targeting is dynamically regulated was not addressed
3. 2021 High

   An unexpected signaling function was uncovered, showing TMCC3 directly binds and activates AKT to drive breast cancer stem cell self-renewal and metastasis—linking the ER protein to oncogenic signaling.

   Evidence Cell-free binding assay, reciprocal Co-IP with domain mapping, siRNA/overexpression, mammosphere and ALDH assays, and xenograft/metastasis models

   PMID:33742122

   Open questions at the time

   • How an ER membrane protein engages cytosolic AKT mechanistically was not resolved
   • Whether AKT activation is connected to TMCC3's ER junction role is unknown
4. 2022 High

   The regulatory logic of TMCC3 junction localization was defined, showing phosphorylation-dependent 14-3-3γ binding to the N-terminus displaces TMCC3 from three-way junctions and remodels the ER network.

   Evidence Reciprocal Co-IP, serine-to-alanine site-directed mutagenesis, overexpression, and knockdown/rescue with ER-morphology readout

   PMID:36549645

   Open questions at the time

   • The kinase that phosphorylates the 14-3-3 binding motif was not identified
   • The physiological signal triggering 14-3-3γ-mediated remodeling was not defined
5. 2024 Medium

   Transcriptional control of TMCC3 was established, identifying PPARγ as a direct activator of Tmcc3 isoforms and linking its upregulation to fatty liver.

   Evidence Reporter assays, EMSA, identification of exon-1 variants, and liver-specific PPARγ knockout in ob/ob mice

   PMID:39326649

   Open questions at the time

   • The functional role of elevated TMCC3 in hepatic lipid metabolism was not established
   • Whether the ER or AKT functions mediate the fatty-liver phenotype is unknown

• How TMCC3's distinct activities—ER three-way junction organization, atlastin support, and direct AKT activation—are mechanistically integrated within one protein remains unresolved.
• No structural model connecting the coiled-coil, AKT-binding, and transmembrane regions
• Whether ER architecture and AKT signaling functions are coupled is unknown